Arndt Vogel, MD, is managing senior consultant and professor in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.  He is head of the GI-Cancer Center and of the Center for Personalized Medicine at Medical School Hannover. 

Prof Vogel’s scientific focus is the translational and clinical research in gastrointestinal cancer. Since 2004, he is leading a basic research group interested in the pathogenesis of GI-cancers with a special focus on hepatobiliary cancers and precision medicine. Arndt Vogel has been a clinical investigator in oncology since 2006 and has served as principal investigator on numerous clinical trials. He is author or co-author of more than 250 articles published in peer-reviewed journals including Lancet Oncology, Cancer Cell, Gastroenterology, and Hepatology.

Prof Vogel is member of societies including ESMO, ASCO, and EASL. He is member and chairman of Hepatobiliary Cancer Study Group of the AIO, a collaborative group in clinical oncology in Germany. Within ESMO, he is member of the ESMO Guidelines Steering Committee. Prof Vogel has responsibilities in the establishment of the national guideline and is the coordinator of the ESMO clinical practice guideline on the management of hepatocellular carcinoma and biliary tract cancer.